Episode summary
Live Nation Reaches DOJ Settlement in Antitrust Case | Bloomberg Intelligence
Bloomberg Intelligence
· · Hosts: Scarlet Fu, Alexis Christoforous · Guests: Jennifer Rie, Madison Muller, Deborah Aitken, Bess Freedman
Summary
Live Nation’s settlement with the Justice Department appears to avoid a forced Ticketmaster breakup, but the case is far from over. An analyst said the agreement seems to center on divesting some large Live Nation-owned amphitheaters and opening parts of the concert pipeline to more competition, while several states, including New York, may keep pressing for a tougher remedy. She argued that even if states win on liability, a judge may still be reluctant to order the drastic step of breaking up the company, and she was skeptical the settlement will quickly make tickets cheaper for consumers.
The episode also covered the surprise rapprochement between Novo Nordisk and Hims & Hers after months of legal conflict over obesity-drug marketing. A health reporter said the two companies are again working together to sell discounted versions of Novo’s weight-loss drugs on Hims’ telehealth platform, a move Wall Street rewarded. She said both companies are under pressure: Hims faces regulatory and legal scrutiny, while Novo is trying to regain share from rivals and from online platforms that have helped distribute cheaper alternatives.
A luxury-goods analyst said the Middle East conflict could meaningfully dent 2026 sector growth, especially if sales in the region slow sharply. She then turned to housing, where the host and a residential broker discussed a market still defined by high rates, low supply and caution among buyers. Cash remains powerful, first-time buyers are older, and the biggest constraint across U.S. housing is still insufficient inventory.
Key takeaways
- An analyst said Live Nation may have to divest some amphitheaters, but Ticketmaster does not appear to be part of the DOJ settlement.
- The analyst argued state plaintiffs could still pursue a Ticketmaster breakup, but she called that remedy a long shot.
- A health reporter said Novo Nordisk and Hims & Hers are partnering again to sell discounted obesity drugs through Hims’ telehealth platform.
- The luxury-goods analyst said a prolonged Middle East conflict could shave about 150 bps from 2026 global organic growth for every 10% slowdown in Middle East sales and 1% elsewhere.
- A residential broker said cash is still king in housing, and the biggest problem remains too little supply, not tighter mortgage credit.
Notable quotes
“it looks like at least one part of it is a divestature. That would be divesting um large amphitheaters that are owned by Live Nation”
“According to the DOJ settlement, it does not have to be sold, but not there are 40 states involved as well”
“if they continue on with the litigation, they will continue to seek a a devestature order from the judge for Live Nation to sell ticket master”
“they are now pairing up for the second time uh to allow Novo to sell discounted versions of its weight loss drugs on him and hers teleahalth platform”
“we went through um some estimates and some data from third party sources”
How the episode opens
Bloomberg Audio Studios, podcasts, radio, news. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m.
Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App. Listen on demand wherever you get your podcasts or watch us live on YouTube. want to bounce off with Live Nation and our next guest, Jennifer Reed, Bloomberg Intelligence, senior litigation analyst.
Um, Jennifer, thanks so much for coming in studio here. We don't know a lot about this Live Nation settlement, right? Uh, maybe we should just start with what do we know,
Right? And it's changing by the minute, by the way. I keep seeing new reports with new details, but it looks like at least one part of it is a divestature.
That would be divesting um large amphitheaters that are owned by Live Nation. The Department of Justice alleged that Live Nation owned 60 out of the 100 top amphitheaters in the US. And the control over those amphitheaters, which the artists really need for summer tours, desire for summer tours, um, was part of the problem, some of the claims that were left in this litigation.
So, selling some of them opens them up to other promoters.
Okay. I guess one big question people had was ticket master, the fate of ticket master and whether that stays with Live Nation or whether it's spun out or the company is forced to sell that. Do we have a firm answer as to what happens to Ticket Master?
Well, not really. According to the DOJ settlement, it does not have to be sold, but not there are 40 states involved as well. They are also plaintiffs and they also have the authority to litigate under federal antitrust laws just as the Department of Justice does.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- live nation ticketmaster antitrust settlement
- ticketing third-party sellers
- novo nordisk hims obesity drugs
- hims compounded ozempic wegovy
- luxury sector middle east war impact
Companies and tickers mentioned
- LYV
- NVO
- HIMS
- Live Nation Entertainment
- Ticketmaster
- Novo Nordisk
- Hims & Hers Health
- Brown Harris Stevens
Watch the episode
Watch “Live Nation Reaches DOJ Settlement in Antitrust Case | Bloomberg Intelligence” on YouTube
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Intelligence
-
Instant Reaction: Nvidia CEO Jensen Huang Ousted by Nvidia Board | Bloomberg Intelligence -
Nvidia’s Huang Ousted by Board in Move That Roils AI Economy | Bloomberg Intelligence -
CoreWeave Shares Soar After AI Computing Firm Eases Debt Fears | Bloomberg Intelligence -
Anthropic Targets $1.4 Trillion Valuation in Blockbuster IPO | Bloomberg Intelligence -
Nvidia Probe Into CEO Affair Raises Thorny Questions for AI | Bloomberg Intelligence -
Election 'Blue Wave' & Your Wallet; Navigating AI-Driven Market Volatility | Bloomberg Intelligence
Bloomberg Intelligence, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.
